Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
Clinical trial NCT02641093 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02641093
- Sponsor
- Trisha Wise-Draper
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2021-04-16
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.